Author + information
Retraction notice to “Does Intracoronary Adenosine Injection During Primary PCI Reduce Microvascular Obstruction in Patients Admitted With STEMI?” [J Am Coll Cardiol 2013;61 Suppl A:A33, E134 in the online version]
Gemina Doolub, Colin Fortar
From Oxford University, Oxford, United Kingdom
This article has been retracted: please see Elsevier Policy on Article Withdrawal (http://www.elsevier.com/locate/withdrawalpolicy).
This article has been retracted at the request of the author.
The prevalence of MVO was reduced in the adenosine-treated patients (45%) compared to 85% of control patients (P=0.0043). We found that the size of MVO in adenosine-treated patients was significantly reduced (0.35g) compared to 0.91 g in the control group (P=0.027). There was no statistically significant difference in TIMI flow and clinical outcomes after primary PCI.
Excel software was used to calculate the p-values. On recalculation using a newer version of the programme, the values are coming back different: Prevalence of MVO comparing adenosine to non-adenosine is now 0.15, therefore non-significant. Also the P-value for the mass of MVO in adenosine versus non-adenosine is 0.34, again non-significant.
- American College of Cardiology Foundation